Featured
Copycats hit PBS bottleneck
Biosimilar and generic drugmakers have emerged as the top contenders to secure an October PBS listing, including one drug that could force a price cut for a $72 million-a-year blockbuster
Regulatory & Reimbursement
Early October listings climb to four
Health Minister Mark Butler announces another two October listings, one of which will benefit more than 143,000 Australians from the start of next month
Regulatory & Reimbursement
TGA approves new flu jab
A new vaccine has been approved by the TGA for adults along with new versions of drugs sponsored by Celltrion Healthcare, Kyowa Kirin, and UCB.
Jobs & Workplace
Another Aussie CEO departs for 'personal reasons'
Leaving after 24 years, this latest exit follows a string of CEO departures across Australia’s biotech sector
Featured
Policy 'earthquake' reshaping pharma
In what's been described as the biggest industry transformation in 30 years, pharma is facing a 'commercialisation reset' on how it does business
Jobs & Workplace
Ex-pharma leader joins fast-growing agency
A corporate and strategic communications advisory agency has buffed up its team with a former J&J and Novartis corporate affairs leader joining the ranks
Industry & Companies
Australia a key market for new platform
Transforming Medical Information into a strategic source of intelligence for pharmas by unlocking more value from every scientific interaction
Regulation & Legal
New law gives patients driving exemption
Medicinal cannabis patients in NSW will no longer have to choose between taking their medicine or driving after reforms abolish automatic license loss and heavy fines
Regulatory & Reimbursement
Another October listing as Govt rushes to beat deadline
A harried Government has announced politically urgent PBS funding for a drug to replace one that is being pulled from the Scheme in November
Industry & Companies
Pharma skyrockets up World's Best Companies list
After placing 43rd last year this pharma has blasted up the rankings to be named the world's fifth best company, trouncing industry rivals
Leadership & People
Who's given Mark Butler an award?
Politicians are more likely cop flak than awards but the Health Minister has won a prestigious gong for his handling of an issue that's sparked a spat between patient groups
Industry & Companies
Amgen releases roadmap for post-cardiac care
With a third of cardiac events being repeats, Amgen has co-authored a report to address gaps in post-hospital care
Featured
PBAC to PBS: the fastest-moving submissions
Two months on from the PBAC's July meeting, just over 60 per cent of the submissions recommended have started progressing towards a PBS listing
Jobs
Leadership & People
Who's been named a top employer?
Judged on leadership, engagement, communication and employee benefits this Big Pharma has taken home a prestigious Australian HR award
Regulatory & Reimbursement
People are dying, where's the access?
A LifeSciences Australia Summit has been told that HTA reforms which the Govt has been sitting on for more than five years are already out of date
Regulation & Legal
A decade on, judge rules biosimilar not infringing
After almost 10 years of legal wrangling over what has become the highest earning biosimilar referencing this one-time blockbuster, a loss for this Big Pharma
Industry & Companies
Second pharma joins Medicines Australia
Another company has joined Medicines Australia as a Class 1 Member this month, with its ANZ chief revealing why it is a pivotal time for industry to speak up
Industry & Companies
$50K research prize up for grabs
Eight finalists tackling some of the most pressing challenges in health and medicine are in the running for funding to boost their research
Regulation & Legal
'Faster acting' claim lands in Federal Court
A series of ads claiming superiority over a competitor has ruffled feathers, with the companies landing in court despite agreeing to mediation
Featured
Significant job cuts hit pharma, with ANZ GM let go
ANZ General Manager among those being let go as “overlapping roles” are made redundant following a recent buyout
Industry & Companies
Sanofi exposes critical ‘GP gap’ in Australia
New data presented by two Sanofi staffers shows GPs hold the key to unlocking both clinical trial participation and representation across Australia
Industry & Companies
Fertility a workplace issue: Merck survey
Nearly two in three young Australians believe employers should provide greater workplace support for people navigating fertility issues
Industry & Companies
Which Big Pharma is changing its name?
One of the world's best known pharmaceutical companies is reportedly changing its name and introducing a new slogan
- Jobs & Workplace Ex-Aussie GM wins global promotion
- Industry & Companies Why Australia can't win against Trump's MFN policy
- Other News Doctors feel the fear but do it anyway
- Industry & Companies 'The Novo Way' marks a new way of working
- Other News Never heard of it: disease gap exposed
- Regulation & Legal Fake Lilly drug causes serious side effect
- Regulatory & Reimbursement Telix lands an FDA three-peat
- Leadership & People GM ANZ role up for grabs
- Regulatory & Reimbursement $113M Novartis drug under threat
- Leadership & People Is Medical Affairs the 'Jan Brady' of pharma?
